Cargando…
Bovine milk immunoglobulins against microbial human diseases
Immunoglobulins (Igs), also called antibodies, are present in milk and colostrum of all lactating species. Igs are divided into classes having different physico-chemical structures and biological activities. The major Ig classes in bovine and human milk are IgA, IgG and IgM. Bovine colostral Igs pro...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152014/ http://dx.doi.org/10.1533/9781845697198.2.269 |
_version_ | 1783521382178488320 |
---|---|
author | Korhonen, H.J. Marnila, P. |
author_facet | Korhonen, H.J. Marnila, P. |
author_sort | Korhonen, H.J. |
collection | PubMed |
description | Immunoglobulins (Igs), also called antibodies, are present in milk and colostrum of all lactating species. Igs are divided into classes having different physico-chemical structures and biological activities. The major Ig classes in bovine and human milk are IgA, IgG and IgM. Bovine colostral Igs provide the newborn calf with passive immune protection against microbial infections until the calf’s own immune system matures. Colostral Ig preparations designed for farm animals have been commercially available for many years. Potential health benefits attributed to bovine colostrum have increased manufacture and marketing of colostral Ig-based dietary supplements also for human use. Furthermore, specific anti-microbial antibodies can be produced into colostrum by immunizing cows with vaccines made of pathogenic microorganisms. These antibodies can be concentrated and used to formulate so-called immune milk preparations. Such preparations have proven effective in prevention of animal and human infections caused, e.g. by rotavirus, Shigella flexneri, Escherichia coli, Clostridium difficile, Streptococcus mutans, Cryptosporidium parvum and Helicobacter pylori. Their therapeutic efficacy, however, seems limited. A few immune milk products have been commercialized and more can be expected in the future for use, e.g. as a supportive means in antibiotic treatments and for prevention of hospital infections. |
format | Online Article Text |
id | pubmed-7152014 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71520142020-04-13 Bovine milk immunoglobulins against microbial human diseases Korhonen, H.J. Marnila, P. Dairy-Derived Ingredients Article Immunoglobulins (Igs), also called antibodies, are present in milk and colostrum of all lactating species. Igs are divided into classes having different physico-chemical structures and biological activities. The major Ig classes in bovine and human milk are IgA, IgG and IgM. Bovine colostral Igs provide the newborn calf with passive immune protection against microbial infections until the calf’s own immune system matures. Colostral Ig preparations designed for farm animals have been commercially available for many years. Potential health benefits attributed to bovine colostrum have increased manufacture and marketing of colostral Ig-based dietary supplements also for human use. Furthermore, specific anti-microbial antibodies can be produced into colostrum by immunizing cows with vaccines made of pathogenic microorganisms. These antibodies can be concentrated and used to formulate so-called immune milk preparations. Such preparations have proven effective in prevention of animal and human infections caused, e.g. by rotavirus, Shigella flexneri, Escherichia coli, Clostridium difficile, Streptococcus mutans, Cryptosporidium parvum and Helicobacter pylori. Their therapeutic efficacy, however, seems limited. A few immune milk products have been commercialized and more can be expected in the future for use, e.g. as a supportive means in antibiotic treatments and for prevention of hospital infections. 2009 2014-03-27 /pmc/articles/PMC7152014/ http://dx.doi.org/10.1533/9781845697198.2.269 Text en Copyright © 2009 Woodhead Publishing Limited. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Korhonen, H.J. Marnila, P. Bovine milk immunoglobulins against microbial human diseases |
title | Bovine milk immunoglobulins against microbial human diseases |
title_full | Bovine milk immunoglobulins against microbial human diseases |
title_fullStr | Bovine milk immunoglobulins against microbial human diseases |
title_full_unstemmed | Bovine milk immunoglobulins against microbial human diseases |
title_short | Bovine milk immunoglobulins against microbial human diseases |
title_sort | bovine milk immunoglobulins against microbial human diseases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152014/ http://dx.doi.org/10.1533/9781845697198.2.269 |
work_keys_str_mv | AT korhonenhj bovinemilkimmunoglobulinsagainstmicrobialhumandiseases AT marnilap bovinemilkimmunoglobulinsagainstmicrobialhumandiseases |